EYE · XBRL financial data

National Vision Holdings financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (EYE's year ends in early January)

In millions of dollars	FY 2020Jan 2, 2021	FY 2021Jan 1, 2022	FY 2022Dec 31, 2022	FY 2023Dec 30, 2023	FY 2024Dec 28, 2024	FY 2025Jan 3, 2026
Revenue from contracts with customers	1,712	2,080	2,005	2,126	1,823	1,987
Selling, general and administrative	721	901	915	992	939	1,016
Total operating expenses	838	1,000	1,019	1,172	1,070	1,109
Other operating income (expense)	0	3	3	0	0	0
Operating income (loss)	87	175	61	(47)	(10)	59
Interest expense	48	26	—	—	—	—
Income tax expense (benefit)	2	21	19	4	1	12
Net income (loss)	36	128	42	(66)	(28)	30
Earnings per share, basic USD per share	0.45	1.57	0.53	(0.84)	(0.36)	0.37
Earnings per share, diluted USD per share	0.44	1.43	0.52	(0.84)	(0.36)	0.37
Weighted average shares, basic millions of shares	81	82	80	78	79	79
Weighted average shares, diluted millions of shares	83	96	80	78	79	81

Fiscal years (EYE's year ends in early January)

In millions of dollars	FY 2020Jan 2, 2021	FY 2021Jan 1, 2022	FY 2022Dec 31, 2022	FY 2023Dec 30, 2023	FY 2024Dec 28, 2024	FY 2025Jan 3, 2026
Cash and cash equivalents	374	306	229	150	74	39
Accounts receivable	58	56	80	87	50	57
Inventory	111	124	123	120	94	89
Prepaid and other current assets	23	29	41	40	32	40
Total current assets	567	515	474	397	250	226
Right-of-use asset	340	355	383	407	409	395
Goodwill	778	778	778	718	698	701
Total assets	2,333	2,293	2,291	2,173	2,008	1,984
Accounts payable	65	64	65	68	54	79
Accrued liabilities	110	119	94	123	109	110
Current portion of long-term debt	0	0	0	8	98	13
Total current liabilities	329	344	344	398	468	412
Long-term debt	625	544	546	438	239	223
Lease liability, non-current	327	342	358	377	366	358
Retained earnings	143	278	321	255	226	256
Total stockholders' equity	907	926	901	829	816	870
Total liabilities and equity	2,333	2,293	2,291	2,173	2,008	1,984
Common shares outstanding (cover page) millions of shares	81	81	79	78	79	79

Fiscal years (EYE's year ends in early January)

In millions of dollars	FY 2020Jan 2, 2021	FY 2021Jan 1, 2022	FY 2022Dec 31, 2022	FY 2023Dec 30, 2023	FY 2024Dec 28, 2024	FY 2025Jan 3, 2026
Net income (loss)	36	128	42	(66)	(28)	30
Stock-based compensation	11	15	14	20	17	24
Net cash from operating activities	235	259	119	173	134	146
Purchases of property and equipment	77	96	114	115	96	73
Net cash from investing activities	(76)	(93)	(111)	(116)	(96)	(77)
Proceeds from issuing common stock	13	12	—	—	—	—
Share repurchases	1	73	84	28	3	3
Proceeds from long-term debt	549	0	0	0	115	25
Repayments of long-term debt	369	167	0	103	222	126
Net cash from financing activities	176	(234)	(85)	(137)	(113)	(105)
Net change in cash	335	(68)	(76)	(80)	(76)	(35)

SIC 3851 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3851 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
National Vision Holdings	36	499	8.1*	79.1M	Q2 FY26 10-QJul 4, 2026
Staar Surgical	149	94	20*	50.1M	Q2 FY26 10-QJul 3, 2026
Warby Parker	293	236	30*	not reported	Q2 FY26 10-QJun 30, 2026
Bausch & Lomb	513	1,375	233*	357.5M	Q3 FY26 10-QSep 30, 2026
RxSight	67	25	45*	41.9M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.